Mettez-vous hors ligne avec l'application Player FM !
S3E4: ‘Forever Young’ with Daniel Ives
Manage episode 436496651 series 2555395
What would you do if you could live to be 100, 125 or even 150? Sure, we all may want to live forever, but what would that actually look like? How would we communicate to those around us? And not only that, is the recent longevity craze feasible or just people with too much time (and money) on their hands?
In this episode, Eva meets with Daniel Ives and has an incredibly exciting and interesting discussion about what he sees as the very real, if not inevitable, space of tackling human aging in a science based way. Trust us, it’s a trip.
Daniel Ives has a PhD from the University of Cambridge, and co-founded Shift Bioscience in 2017.
LINKS
www.twitter.com/TheLifeCyclePod
www.instagram.com/thelifecyclepodcast
www.thelifecyclepodcast.com
www.klang-games.com
Discord
26 episodes
Manage episode 436496651 series 2555395
What would you do if you could live to be 100, 125 or even 150? Sure, we all may want to live forever, but what would that actually look like? How would we communicate to those around us? And not only that, is the recent longevity craze feasible or just people with too much time (and money) on their hands?
In this episode, Eva meets with Daniel Ives and has an incredibly exciting and interesting discussion about what he sees as the very real, if not inevitable, space of tackling human aging in a science based way. Trust us, it’s a trip.
Daniel Ives has a PhD from the University of Cambridge, and co-founded Shift Bioscience in 2017.
LINKS
www.twitter.com/TheLifeCyclePod
www.instagram.com/thelifecyclepodcast
www.thelifecyclepodcast.com
www.klang-games.com
Discord
26 episodes
Tous les épisodes
×Bienvenue sur Lecteur FM!
Lecteur FM recherche sur Internet des podcasts de haute qualité que vous pourrez apprécier dès maintenant. C'est la meilleure application de podcast et fonctionne sur Android, iPhone et le Web. Inscrivez-vous pour synchroniser les abonnements sur tous les appareils.